http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 진선아(Jin Sun-Ah) (검색결과 4 건)
- 무료
- 기관 내 무료
- 유료
-
경추부 이상 환자의 경ㆍ요추부 운동이 척주 만곡 및 체중심 이동에 미치는 영향
진선아(Jin Sun-Ah),우지혜(Woo Ji-Hae),정호발(Jung Ho-Bal) 대한치료과학회 2013 대한치료과학회지 Vol.5 No.2
Objective: The purpose of this study was to restore the balance of the whole body and resolve cervical spine problems, such as cervical curve deformity, by applying cervico-lumbar exercises in cervical spine patients. Method: Twenty-seven patients with 5° or larger cervical curve deviations were selected from patients at T Hospital and were randomly divided into a cervical exercise group and a cervico-lumbar exercise group. The cervical curves, including the cervical lordotic angle, thoracic kypotic angle, lumbar lordotic angle, and Ferguson angle, of both groups were measured using X-rays. The values of body alignment, including the ear, acromion, great trochanter, lateral epicondyle of the knee joint, and malleous, were measured using dynamic posturography. Eight weeks after the measurements, both groups were re-measured to compare the results before and after the experiment. Paired t-tests and an ANCOVA were employed to analyze differences in the averages of the two groups and to perform a comparative analysis with the experimental phase. Results: The within-group comparison showed that both groups had statistically significant changes in the cervical lordotic angle before and after the experiment(p<.05). Regarding the values of body alignment, the control group showed no statistically significant changes in the ear, acromion, and great trochanter(p<.05), whereas the test group exhibited statistically significant changes in the same variables. Conclusion: In this study of cervical spine patients, the application of cervico-lumbar exercises was more effective than cervical exercises.
-
암환자의 통증치료에 대한 $Ultracet^{(R)}$의 유효성과 안전성
이효진,진선아,윤각원,양영준,박남환,천재민,박남숙,윤환중,조덕연,김삼용,Lee, Hyo-Jin,Jin, Sun-Ah,Yun, Gak-Won,Yang, Yung-Joon,Park, Nam-Whan,Chun, Jae-Min,Park, Nam-Sook,Yun, Hwan-Jung,Jo, Deog-Yeon,Kim, Sam-Yong 한국호스피스완화의료학회 2006 한국호스피스.완화의료학회지 Vol.9 No.2
목적: 외래에 내원하는 암환자들을 대상으로 암성통증의 조절에 있어서 $Ultracet^{(R)}$의 효과와 안전성에 대해 알아보고자 하였다. 방법: 암으로 진단을 받고 통증 조절을 목적으로 $Ultracet^{(R)}$을 투여한 61명의 환자를 대상으로 통증조절의 정도와 통증이 환자의 삶의 질에 미치는 영향에 대한 평가를 위해 Korean version of Brief Pain Inventory를 이용하였다. 약물의 안전성은 복용 후 나타나는 부작용 정도에 의하여 평가하였다. 결과: 대상환자의 평균연령은 59.9세였고 성별분포는 남자가 34명, 여자가 27명이었다. 환자의 진단은 폐암, 위암, 육종, 대장암, 췌장암, 자궁 경부암, 두경부암, 그리고 림프종 등의 순이었다. 대상환자에서 가장 심했을 때의 통증 정도는 $Ultracet^{(R)}$을 사용하기 전후에 유의한 감소를 보이지 않았으나($5.18{\pm}1.41\;vs.\;4.82{\pm}1.94$; P=0.113), 가장 약했을 때의 통증 정도($1.2{\pm}1.05\;vs.\;0.87{\pm}1.35$; P=0.038), 환자가 느끼는 통증의 평균 정도($3.65{\pm}1.01\;vs.\;3.13{\pm}1.73$: P=0.022)와 바로 지금 느끼는 통증정도($3.63{\pm}1.25\;vs.\;2.85{\pm}1.94$; P=0.003)는 유의하게 감소되었다. $Ultracet^{(R)}$의 사용으로 인한 부작용은 전반적으로 경미하여 2도의 오심과 구토 각 1예와 1도의 변비, 소양증, 안면 홍조가 각각 1예씩 관찰되었으나 3도나 4도의 독성은 관찰되지 않았다. 결론: $Ultracet^{(R)}$은 외래환경에서 암환자의 통증조절에 있어서 안전하게 사용할 수 있는 비교적 효과적인 약물로 생각된다. Purpose: We aimed to investigate the efficacy and side effects of $Ultracet^{(R)}$ in relieving cancer pain in setting. Methods: Sixty-one cancer patients over 18 years old, who had cancer pain with or without medication, were enrolled. Pain and other variables were evaluated before and after treatment with $Ultracet^{(R)}$ for 2 weeks, using Korean version of Brief Pain Inventory. Results: Of 61 patients with assessable efficacy data, the maximum pain intensity(PI) experienced in a day were $5.18{\pm}1.41\;and\;4.82{\pm}1.94$, before and after treatment with$Ultracet^{(R)}$ respectively (P=0.113). The minimum PI experienced in a day were $1.2{\pm}1.05\;and\;0.87{\pm}1.35$, before and after treatment with $Ultracet^{(R)}$, respectively (P=0.038). The average PI experienced in a day were $3.61{\pm}1.01\;and\;3.15{\pm}1.73$, before and after treatment with $Ultracet^{(R)}$, respectively (P=0.022). The current PI were $3.63{\pm}1.25\;and\;2.85{\pm}1.94$, before and after treatment with $Ultracet^{(R)}$, respectively (P=0.003). Regarding the quality of life, only mood changed for the better in 49 patients who were treated with $Ultracet^{(R)}$ alone ($1.98{\pm}1.73\;and\;1.35{\pm}1.15$, before and after treatment respectively; P=0.046). There were five (8.2%) adverse events associated with $Ultracet^{(R)}$ treatment. Conclusion: $Ultracet^{(R)}$ seems effective and safe in ambulatory patients with cancer pain.
-
ST분절 상승 심근경색증 환자에서 시간 지연이 사망률에 미치는 영향
박용규 ( Yong Kyu Park ),정진옥 ( Jin Ok Jeong ),박재호 ( Jae Ho Park ),이현석 ( Hyeon Seok Lee ),이영달 ( Young Dal Lee ),최웅림 ( Ung Lim Choi ),진선아 ( Sun Ah Jin ),신성균 ( Sung Kyun Sin ),김준형 ( Jun Hyung Kim ),박재형 ( Ja 대한내과학회 2011 대한내과학회지 Vol.81 No.2
Background/Aims: The delay between the onset of myocardial infarction symptoms and primary percutaneous coronary intervention (PCI) is an important prognostic factor in patients with ST-segment elevation acute myocardial infarction (STEMI).We reviewed this delay in patients with STEMI and analyzed clinical outcomes. Methods: The study enrolled 3,399 patients (age, 61.4±12.8 years; 25.6% women) with STEMI who underwent primary PCIwithin 12 hours of symptom onset between October 2005 and February 2008 from the Korea Acute Myocardial Infarction Registry.The patients were divided into two groups according to the symptom-to-balloon time: group I (≤ 3 hours, n=955) and group II (>3 hours, n=2444). The in-hospital mortality rates and 1-year mortality and major adverse cardiac event (MACE) rates werecompared between the two groups. Results: The mean time interval from the onset of symptoms to arrival at the emergency room (ER) was 188.0±133.6 minutes(median, 152 minutes). The mean time interval from the ER to reperfusion (door-to-balloon time) was 97.8±67.9 minutes (median,80 minutes). The mean time interval from the onset of symptoms to reperfusion (symptom-to-balloon time) was 285.8±146.2minutes (median 250 minutes). The in-hospital mortality rate was significantly lower in group I as compared with group II (3.6%versus 5.2%, p=0.044). The 1-year mortality rate was also significantly lower in group I (4.7% versus 7.2%, p=0.012), while the1-year MACE rate was not significantly different between groups (17.9% versus 20.4%, p=0.179). Conclusions: This study demonstrates that there is a significant pre-hospital time delay in patients with STEMI in Korea and this time delay is associated with increased 1-year mortality. (Korean J Med 2011;81:199-207)
-
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
